These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11427623)

  • 1. Renoprotective and anti-hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen-2)27 rat.
    Wilkinson-Berka JL; Gibbs NJ; Cooper ME; Skinner SL; Kelly DJ
    Nephrol Dial Transplant; 2001 Jul; 16(7):1343-9. PubMed ID: 11427623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.
    Mifsud SA; Skinner SL; Cooper ME; Kelly DJ; Wilkinson-Berka JL
    J Am Soc Nephrol; 2002 Mar; 13(3):684-692. PubMed ID: 11856772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy.
    Jacobsen P; Andersen S; Jensen BR; Parving HH
    J Am Soc Nephrol; 2003 Apr; 14(4):992-9. PubMed ID: 12660333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension.
    Anan F; Takahashi N; Ooie T; Yufu K; Hara M; Nakagawa M; Yonemochi H; Saikawa T; Yoshimatsu H
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):353-9. PubMed ID: 15918057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
    Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
    Clin Exp Nephrol; 2013 Feb; 17(1):41-50. PubMed ID: 23011292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
    Davis BJ; Forbes JM; Thomas MC; Jerums G; Burns WC; Kawachi H; Allen TJ; Cooper ME
    Diabetologia; 2004 Jan; 47(1):89-97. PubMed ID: 14647892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat.
    Kelly DJ; Skinner SL; Gilbert RE; Cox AJ; Cooper ME; Wilkinson-Berka JL
    Kidney Int; 2000 May; 57(5):1882-94. PubMed ID: 10792607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade.
    Mifsud SA; Allen TJ; Bertram JF; Hulthen UL; Kelly DJ; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Diabetologia; 2001 Jul; 44(7):878-82. PubMed ID: 11508273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
    Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
    Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats.
    Kelly DJ; Wilkinson-Berka JL; Ricardo SD; Cox AJ; Gilbert RE
    Nephrol Dial Transplant; 2002 Jun; 17(6):985-91. PubMed ID: 12032186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
    Davis BJ; Cao Z; de Gasparo M; Kawachi H; Cooper ME; Allen TJ
    J Hypertens; 2003 Jan; 21(1):209-16. PubMed ID: 12544453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
    Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal dysfunction in diabetic ren-2 rats is ameliorated by treatment with valsartan but not atenolol.
    Phipps JA; Wilkinson-Berka JL; Fletcher EL
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):927-34. PubMed ID: 17251496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats].
    Chen B; Zhang Y; Liu G; Guan GJ; Hou XH; Li XG; Liu JL
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):540-5. PubMed ID: 18649770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):76-85. PubMed ID: 15730439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR).
    Kelly DJ; Wilkinson-Berka JL; Allen TJ; Cooper ME; Skinner SL
    Kidney Int; 1998 Aug; 54(2):343-52. PubMed ID: 9690200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    O'Brien RC; Cooper ME; Jerums G; Doyle AE
    Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.